2017
DOI: 10.21294/1814-4861-2017-16-2-27-35
|View full text |Cite
|
Sign up to set email alerts
|

Role of Transforming Growth Factor Receptor B I Type (Tgf-Bri) in the Progression of the Luminal Breast Cancer Subtype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 1 publication
(1 reference statement)
0
1
0
Order By: Relevance
“…It is known that luminal types are associated with a less aggressive course and a favourable prognosis compared to HER2/Neu+ and triple-negative breast cancer subtypes (Chen et al, 2019). A triple-negative subtype is associated with a high frequency of breast cancer (BRCA1) mutations, aggressive course, lack of response to chemotherapy and hormone therapy, and low survival rates (Alizadehmohajer et al, 2020;Babyshkina et al, 2017).…”
Section: Comparative Analysis Of Vaginal Microbiota In Women With Breast Cancer In Kazakhstanmentioning
confidence: 99%
“…It is known that luminal types are associated with a less aggressive course and a favourable prognosis compared to HER2/Neu+ and triple-negative breast cancer subtypes (Chen et al, 2019). A triple-negative subtype is associated with a high frequency of breast cancer (BRCA1) mutations, aggressive course, lack of response to chemotherapy and hormone therapy, and low survival rates (Alizadehmohajer et al, 2020;Babyshkina et al, 2017).…”
Section: Comparative Analysis Of Vaginal Microbiota In Women With Breast Cancer In Kazakhstanmentioning
confidence: 99%